185 related articles for article (PubMed ID: 15610616)
1. Qualitative and quantitative analysis of clopidogrel bisulphate polymorphs.
Koradia V; Chawla G; Bansal AK
Acta Pharm; 2004 Sep; 54(3):193-204. PubMed ID: 15610616
[TBL] [Abstract][Full Text] [Related]
2. Quantifying low levels of polymorphic impurity in clopidogrel bisulphate by vibrational spectroscopy and chemometrics.
Német Z; Demeter A; Pokol G
J Pharm Biomed Anal; 2009 Jan; 49(1):32-41. PubMed ID: 19019611
[TBL] [Abstract][Full Text] [Related]
3. Development and metrological characterization of quantitative X-ray diffraction phase analysis for the mixtures of clopidogrel bisulphate polymorphs.
Uvarov V; Popov I
J Pharm Biomed Anal; 2008 Mar; 46(4):676-82. PubMed ID: 18191358
[TBL] [Abstract][Full Text] [Related]
4. Effect of sample preparation method on quantification of polymorphs using PXRD.
Alam S; Patel S; Bansal AK
Pharm Dev Technol; 2010; 15(5):452-9. PubMed ID: 19842910
[TBL] [Abstract][Full Text] [Related]
5. Characterization of degradation products of amorphous and polymorphic forms of clopidogrel bisulphate under solid state stress conditions.
Raijada DK; Prasad B; Paudel A; Shah RP; Singh S
J Pharm Biomed Anal; 2010 Jul; 52(3):332-44. PubMed ID: 19520540
[TBL] [Abstract][Full Text] [Related]
6. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
Bellur Atici E; Karlığa B
J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
[TBL] [Abstract][Full Text] [Related]
7. Formulation of tablets containing an 'in-process' amorphized active pharmaceutical ingredient.
Jójárt-Laczkovich O; Szabó-Révész P
Drug Dev Ind Pharm; 2011 Nov; 37(11):1272-81. PubMed ID: 21457129
[TBL] [Abstract][Full Text] [Related]
8. [Polymorphs of clopidogrel bisulfate].
Liu Y; Huang HW; Wu JM; Shi YQ; Yang LH
Yao Xue Xue Bao; 2013 Aug; 48(8):1358-60. PubMed ID: 24187849
[TBL] [Abstract][Full Text] [Related]
9. Quantitative determination of polymorphic impurity by X-ray powder diffractometry in an OROS formulation.
Varasteh M; Deng Z; Hwang H; Kim YJ; Wong GB
Int J Pharm; 2009 Jan; 366(1-2):74-81. PubMed ID: 18840515
[TBL] [Abstract][Full Text] [Related]
10. IR spectroscopy together with multivariate data analysis as a process analytical tool for in-line monitoring of crystallization process and solid-state analysis of crystalline product.
Pöllänen K; Häkkinen A; Reinikainen SP; Rantanen J; Karjalainen M; Louhi-Kultanen M; Nyström L
J Pharm Biomed Anal; 2005 Jun; 38(2):275-84. PubMed ID: 15925219
[TBL] [Abstract][Full Text] [Related]
11. Similarity of solid state structures of R- and S-isomers of clopidogrel hydrogensulphate salt.
Zupancic V; Kotar-Jordan B; Plevnik M; Smrkolj M; Vrecer F
Pharmazie; 2010 May; 65(5):389-90. PubMed ID: 20503936
[TBL] [Abstract][Full Text] [Related]
12. Quantitative nondestructive methods for the determination of ticlopidine in tablets using reflectance near-infrared and Fourier transform Raman spectroscopy.
Markopoulou CK; Koundourellis JE; Orkoula MG; Kontoyannis CG
Appl Spectrosc; 2008 Feb; 62(2):251-7. PubMed ID: 18284803
[TBL] [Abstract][Full Text] [Related]
13. Characterization of solid-state forms of mebendazole.
Kumar S; Chawla G; Sobhia ME; Bansal AK
Pharmazie; 2008 Feb; 63(2):136-43. PubMed ID: 18380400
[TBL] [Abstract][Full Text] [Related]
14. New clopidogrel napadisilate salt and its solid dispersion with improved stability and bioequivalence to the commercial clopidogrel bisulphate salt in beagle dogs.
Kim YI; Kim KS; Suh KH; Shanmugam S; Woo JS; Yong CS; Choi HG
Int J Pharm; 2011 Aug; 415(1-2):129-39. PubMed ID: 21645599
[TBL] [Abstract][Full Text] [Related]
15. Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study.
Német Z; Kis GC; Pokol G; Demeter A
J Pharm Biomed Anal; 2009 Feb; 49(2):338-46. PubMed ID: 19131203
[TBL] [Abstract][Full Text] [Related]
16. Multiple approaches to pharmaceutical polymorphism investigation--a case study.
Li H; Kiang YH; Jona J
Eur J Pharm Sci; 2009 Dec; 38(5):426-32. PubMed ID: 19748574
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of photostability of solid-state nicardipine hydrochloride polymorphs by using Fourier-transformed reflection-absorption infrared spectroscopy - effect of grinding on the photostability of crystal form.
Teraoka R; Otsuka M; Matsuda Y
Int J Pharm; 2004 Nov; 286(1-2):1-8. PubMed ID: 15500997
[TBL] [Abstract][Full Text] [Related]
18. Mebendazole crystal forms in tablet formulations. An ATR-FTIR/chemometrics approach to polymorph assignment.
Calvo NL; Kaufman TS; Maggio RM
J Pharm Biomed Anal; 2016 Apr; 122():157-65. PubMed ID: 26874854
[TBL] [Abstract][Full Text] [Related]
19. Identification and quantitative determination of atorvastatin calcium polymorph in tablets using FT-Raman spectroscopy.
Skorda D; Kontoyannis CG
Talanta; 2008 Jan; 74(4):1066-70. PubMed ID: 18371751
[TBL] [Abstract][Full Text] [Related]
20. Identification of the mebendazole polymorphic form present in raw materials and tablets available in South Africa.
Liebenberg W; Dekker TG; Lötter AP; de Villiers MM
Drug Dev Ind Pharm; 1998 May; 24(5):485-8. PubMed ID: 9876612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
